These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 28117274)

  • 1. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
    Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y
    J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
    Li YX; Run L; Shi T; Zhang YJ
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schisandrin B inhibits TGF-β1-induced epithelial-mesenchymal transition in human A549 cells through epigenetic silencing of ZEB1.
    Zhuang W; Li Z; Dong X; Zhao N; Liu Y; Wang C; Chen J
    Exp Lung Res; 2019; 45(5-6):157-166. PubMed ID: 31268360
    [No Abstract]   [Full Text] [Related]  

  • 4. Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways.
    Liu Y; Cao Y; Sun S; Zhu J; Gao S; Pang J; Zhu D; Sun Z
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):141-154. PubMed ID: 27297622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of asiaticoside for TGF-β1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension.
    Wang XB; Wang W; Zhu XC; Ye WJ; Cai H; Wu PL; Huang XY; Wang LX
    Life Sci; 2015 Sep; 137():56-64. PubMed ID: 26209140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schisandrin B suppresses TGFβ1-induced stress fiber formation by inhibiting myosin light chain phosphorylation.
    Chun JN; Kim SY; Park EJ; Kwon EJ; Bae DJ; Kim IS; Kim HK; Park JK; Lee SW; Park HH; So I; Jeon JH
    J Ethnopharmacol; 2014 Mar; 152(2):364-71. PubMed ID: 24486209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-apoptosis endothelial cell-secreted microRNA-195-5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension.
    Zeng Z; Yao J; Li Y; Xue Y; Zou Y; Shu Z; Jiao Z
    J Cell Biochem; 2018 Feb; 119(2):2144-2155. PubMed ID: 28862358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercapnia downregulates hypoxia-induced lysyl oxidase expression in pulmonary artery smooth muscle cells via inhibiting transforming growth factor β
    Xia XD; Peng YP; Lei D; Chen WQ
    Cell Biochem Funct; 2019 Apr; 37(3):193-202. PubMed ID: 30917408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
    Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
    Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpain-2 activates Akt via TGF-β1-mTORC2 pathway in pulmonary artery smooth muscle cells.
    Abeyrathna P; Kovacs L; Han W; Su Y
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C24-34. PubMed ID: 27099352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling.
    Li P; Song J; Du H; Lu Y; Dong S; Zhou S; Guo Z; Wu H; Zhao X; Qin Y; Zhu N
    J Mol Cell Cardiol; 2021 Dec; 161():9-22. PubMed ID: 34339758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of schisandrin B on lung mRNA expression of transforming growth factor-beta1 signal transduction molecule in rat lungs exposed to silica].
    Fan LH; Liu TF; Guo M; Liu ML; Wang ZP; Si SJ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Apr; 29(4):255-9. PubMed ID: 21941776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
    Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL
    Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1.
    Yu L; Tu Y; Jia X; Fang K; Liu L; Wan L; Xiang C; Wang Y; Sun X; Liu T; Yu D; Cao W; Song Y; Fan Y
    Cell Physiol Biochem; 2017; 42(1):55-67. PubMed ID: 28494457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
    Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
    Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats.
    Li XW; Du J; Hu GY; Hu CP; Li D; Li YJ; Li XH
    Can J Physiol Pharmacol; 2014 Jan; 92(1):58-69. PubMed ID: 24383874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl
    Zhang H; Chen Q; Dahan A; Xue J; Wei L; Tan W; Zhang G
    Chem Biol Interact; 2019 Aug; 309():108675. PubMed ID: 31150632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
    Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.